Today: 30 June 2026
Browse Category

NASDAQ:DXCM 7 July 2025 - 15 May 2026

US Stock Market Today: Nasdaq Futures Slide as Oil Shock and Treasury Yields Hit Wall Street

US Stock Market Today: Nasdaq Futures Slide as Oil Shock and Treasury Yields Hit Wall Street

U.S. stock futures tumbled ahead of Friday’s opening bell. Nasdaq 100 and S&P 500 contracts both slid over 1%, as rising Treasury yields and stronger oil prices threatened Wall Street’s run of records. By 5:38 a.m. ET, Dow E-minis were off 330 points, or 0.66%. S&P 500 E-minis shed 1.07%, with Nasdaq 100 E-minis down 1.56%. In premarket moves, Applied Materials fell, airlines were weaker, but Dexcom traded higher. The selloff is biting right where it hurts U.S. stocks most—AI-fueled gains and the belief that rate hikes were finished. The 10-year Treasury yield pushed up to around 4.54%. Brent crude sat close to $109 a barrel, squeezing growth stocks that lean hard on future profits. “The rally may exhausts itself a little bit,” said Tim Graf at State Street Markets.
15 May 2026
······
DexCom Stock Plunge Raises Big Questions – Will This Diabetes Tech Leader Rebound?

DexCom Stock Plunge Raises Big Questions – Will This Diabetes Tech Leader Rebound?

DexCom’s Q3 2025 earnings were better than expected, but the celebration was short-lived. The headline numbers were strong – $1.209 B revenue and $0.61 adjusted EPS – beating consensus on bothinvesting.com. In fact, demand for DexCom’s G7 continuous glucose monitors drove 20% organic growth globally, with U.S. sales up 21% and international up 18% YoYinvesting.com. Off the back of this strength, management raised full-year 2025 guidance, now targeting ~$4.63 B revenueinvestors.dexcom.com and improved operating margins around 20–21%. However, on the earnings call DexCom’s interim CEO Jake Leach delivered news that rattled the market: early hints at 2026 guidance suggest growth may not hit Wall Street’s lofty targetsreuters.com. Leach indicated that while 2026 should still see solid double-digit revenue gains, the “top end” of DexCom’s internal forecast is slightly below where analysts’ estimates are todayreuters.com. In other words, DexCom is signaling a bit of a slowdown in growth momentum next year relative to expectations.
31 October 2025
·
Global Wearable Health Tech News – June and July 2025

Global Wearable Health Tech News – June and July 2025

The months of June and July 2025 have been packed with developments in wearable devices and health-sensing technology. This report compiles global news from this period, including major product launches, breakthroughs in wearable health sensors, key regulatory approvals, emerging market trends and forecasts, recent clinical research findings, and notable expert commentary. The focus is on authoritative sources such as company press releases, medical journals, regulatory announcements, and reputable news outlets. Each section below is structured to provide a clear overview of the latest happenings, with sources cited for verification. Several companies – from startups to tech giants – unveiled new wearable health-tech products or collaborations in this period. These range from advanced vital-sign monitors to integrated diabetes management devices. The table below summarizes some key announcements:
7 July 2025
···

Stock Market Today

  • Foreign Funds Raise Flags Over Japan's Move Toward Economic Nationalism
    June 29, 2026, 6:41 PM EDT. Foreign investors are worried Japan could be moving away from reform and turning toward economic nationalism. A private equity executive said the pendulum is swinging from open markets and liberal rules, which could hurt investor confidence. The shift could make Japan less appealing to foreign capital as countries vie for investment. Some investors are calling on Tokyo to stick with reforms to keep growth and international ties on track.
Go toTop